|
FOR
IMMEDIATE RELEASE
June
13, 2005.
Guava
Technologies, Inc. has introduced a new side scatter option for
its Guava EasyCyte™ system that makes single-cell analysis with
accurate cell enumeration more versatile and easier than ever before.
Enhancing
single-cell analysis with accurate cell enumeration
Guava
Technologies, Inc. has introduced a new side scatter option for
its Guava EasyCyte™ system that makes single-cell analysis with
accurate cell enumeration more versatile and easier than ever before.

The
side scatter feature allows researchers to analyse whole blood for
different types of white blood cells, without having to stain or
fix the cells. The granular structures in the cytoplasm of granulocytes,
a type of white blood cell, cause more scattering of incident light
than the more uniform cytoplasm of lymphocytes, another type of
white blood cell. This makes it easier to perform a three-part differential
on whole blood: assessing the percentage and number of granulocytes,
monocytes, and lymphocytes in a given sample.
"The
addition of side scatter will expand our opportunities in the immunology
and oncology markets," said Larry Bruder, Guava vice president,
worldwide marketing and business development. "Addition of
side scatter functionality supports our goal to bring accessible
and powerful, yet cost-effective cytometry to the life sciences
market." Side scatter is also used for a variety of others
applications within the life sciences market, such as a QC measure
for cell line sample integrity, as a way to eliminate debris from
your sample, or to discern infected from non-infected cells.
The
Guava EasyCyte is a five-parameter system that is flexible, highly
affordable, and ultra-compact. Since it requires only a few microlitres
of sample volume, it saves precious and expensive cells, reagents,
and compounds. The system is so easy to use, results are generated
with less than a day's training. The Guava EasyCyte system runs
each of Guava's turnkey assays, enabling easy, fast measurements
of cell counting/viability, GFP expression and viability, apoptosis,
cell cycle analysis, antigen detection, cell tracking, and more.
Guava
Technologies, Inc., a privately held biotechnology and medical device
company, is the leading provider of on-demand, easy-to-use single
cell analysis systems. The Guava Personal Cell Analysis (PCA™) systems,
including the Guava PCA, Guava PCA-96 and Guava EasyCyte systems,
are integrated, fully optimised, micro-capillary cytometry systems
with embedded absolute cell counting capability. Used worldwide
by the life sciences, biotechnology, pharmaceutical industries,
and clinical testing institutions (outside the United States and
Europe), Guava's products have broad applications in scientific
research and throughout the drug discovery and lead optimisation
process, as well as for cell counting and optimisation of commercial
bio-pharmaceutical production. Guava offers a variety of assays
and dedicated software modules for the Guava PCA systems, enhancing
the system's overall ease-of-use.
More
information about the company and its products is available at www.guavatechnologies.com
CONTACTS:
|